Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Expanded Access for TNB-383B in a Subject With Relapsed/Refractory Multiple Myeloma
- Conditions
- Multiple Myeloma
- First Posted Date
- 2020-07-01
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- TeneoOne Inc.
- Registration Number
- NCT04453397
- Locations
- 🇺🇸
Wake Forest, Winston-Salem, North Carolina, United States
A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma
- First Posted Date
- 2019-05-01
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- TeneoOne Inc.
- Target Recruit Count
- 220
- Registration Number
- NCT03933735
- Locations
- 🇺🇸
University of California San Francisco (UCSF) - Parnassus Heights /ID# 238680, San Francisco, California, United States
🇺🇸Tulane University School of Medicine /ID# 242322, New Orleans, Louisiana, United States
🇺🇸Mayo Clinic - Rochester /ID# 238683, Rochester, Minnesota, United States
News
No news found